sfr
sfr   ACCUEIL
sfr   L'ASSOCIATION
sfr   BUREAU
sfr   MEMBRES
sfr   CONFÉRENCES ET
PUBLICATIONS
sfr   NOUS REJOINDRE
sfr   CORRESPONDANCE
sfr   PARTENAIRES
sfr   CONTACTS
 
Manifestations Revue Cas cliniques Prix Bibliographie
 
Diabète : Recherche
 

Abu El-Asrar, A.M., et al.
Expression of antiapoptotic and proapoptotic molecules in diabetic retinas.
Eye, 2007. 21(2): p. 238-45.

Gilmore, E.D., et al.
Retinal arteriolar diameter, blood velocity, and blood flow response to an isocapnic hyperoxic provocation in early sight-threatening diabetic retinopathy.
Invest Ophthalmol Vis Sci, 2007. 48(4): p. 1744-50.

Glenn, J.V., et al.,
Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging.
Faseb J, 2007.

Globocnik Petrovic, M., et al.
Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy.
Am J Ophthalmol, 2007. 143(1): p. 175-6.

Kawashima, M., et al.,
Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
Jpn J Ophthalmol, 2007. 51(2): p. 100-4.

Kersten, S.
Peroxisome proliferator activated receptors and obesity.
Eur J Pharmacol, 2002. 440(2-3): p. 223-34.

Kifley, A.W., et al.,
Retinal vascular caliber, diabetes, and retinopathy.
Am J Ophthalmol, 2007. 143(6): p. 1024-6.

Lofqvist, C. et al.
IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth
Proc Natl Acad Sci U S A. 2007. 104(25): p. 10589-94

Loukovaara, S., et al.,
Glycodelin a novel serum anti-inflammatory marker in type 1 diabetic retinopathy during pregnancy.
Acta Ophthalmol Scand, 2007. 85(1): p. 46-9.

Lupien, C.B. and C. Salesse
Characterization of two spontaneously generated human muller cell lines from donors with type 1 and type 2 diabetes.
Invest Ophthalmol Vis Sci, 2007. 48(2): p. 874-80

Maa AY, Sullivan BR.
Relationship of hemoglobin A1C with the presence and severity of retinopathy upon initial screening of Type II diabetes mellitus.
Am J Ophthalmol. 2007 Sep;144(3):456-7.

McLeod, D.,
A chronic grey matter penumbra, lateral microvascular intussusception and venous peduncular avulsion underlie diabetic vitreous haemorrhage.
Br J Ophthalmol, 2007. 91(5): p. 677-89.

Nayak, R.C., et al.
Circulating antipericyte autoantibodies : a novel modifier of risk of progression of diabetic retinopathy ?
Retina, 2007. 27(2): p. 211-5.

Prasad P et al.
Association of TGFbeta1, TNF alpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians.
BMC Med Genet. 2007 Apr 12;8:20.

Roldan-Pallares, M., et al.
Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Retina, 2007. 27(2): p. 222-35.

Sawada, O.K., H. Kakinoki, M. Sawada, T. Ohji, M.
Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.
Arch Ophthalmol, 2007. 125(10): p. 1363-6.

Shelton MD, Kern TS, Mieyal JJ.
Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Muller cells: model of diabetic retinopathy.
J Biol Chem. 2007 Apr 27;282(17):12467-74.

Takebayashi, K., et al.
Retinol binding protein-4 levels and clinical features of type 2 diabetes patients.
J Clin Endocrinol Metab, 2007.

Toda, N.N.-T., M.,
Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy.
Prog Retin Eye Res, 2007. 26(3): p. 205-38.

Unoki, N., et al.
Retinal sensitivity loss and structural disturbance in areas of capillary nonperfusion of eyes with diabetic retinopathy.
Am J Ophthalmol, 2007. 144(5): p. 755-760.

Uthra, S. et al.
Intron 4 VNTR of endothelial nitric oxide synthase (eNOS) gene and diabetic retinopathy in type 2 patients in southern India
Ophthalmic Genet, 2007. 28(2): p.77-81

Ucgun NIet al.
The importance of serum lipids in exudative diabetic macular edema in type 2
diabetic patients.
Ann N Y Acad Sci. 2007 Apr;1100:213-7.

Yildirim Z, et al.
Antioxidant enzymes and diabetic retinopathy.
Ann N Y Acad Sci. 2007 Apr;1100:199-206

<< DMLA : Nutrition
Diabète : Epidémiologie >>


RETOUR A LA LISTE
Accueil | Manifestations | Revue | Cas Cliniques | Prix | Contacts | Conferences et publications
Un site du portail Affinité Santé
Société Française de Rétine - 40, avenue de Verdun 94010 CRETEIL - Tél. 01 45 17 52 25 Fax. 01 45 17 52 27
sfr